CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
: PhP Trientinum-150mg-Tablet - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:AdministrableProductDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "PhP-Trientinum-250mg-Capsule"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"^^xsd:anyURI ;
fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition PhP-Trientinum-250mg-Capsule</b></p><a name=\"PhP-Trientinum-250mg-Capsule\"> </a><a name=\"hcPhP-Trientinum-250mg-Capsule\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-administrableproductdefinition.html\">CH IDMP AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Triogen-250mg-Capsule.html\">MedicinalProductDefinition: extension = Capsule, hard,TRIOGEN wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7601001403062-6743101; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10210000}\">Capsule, hard</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{http://standardterms.edqm.eu 15012000}\">Capsule</span></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20053000}\">Oral use</span></td></tr></table></div>"^^rdf:XMLLiteral
] ; #
fhir:status [ fhir:v "active"] ; #
fhir:formOf ( [
fhir:reference [ fhir:v "MedicinalProductDefinition/Triogen-250mg-Capsule" ]
] ) ; #
fhir:administrableDoseForm [
( fhir:coding [
fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
fhir:code [ fhir:v "10210000" ] ;
fhir:display [ fhir:v "Capsule, hard" ] ] )
] ; #
fhir:unitOfPresentation [
( fhir:coding [
fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
fhir:code [ fhir:v "15012000" ] ;
fhir:display [ fhir:v "Capsule" ] ] )
] ; #
fhir:routeOfAdministration ( [
fhir:code [
( fhir:coding [
fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
fhir:code [ fhir:v "20053000" ] ;
fhir:display [ fhir:v "Oral use" ] ] ) ]
] ) . #
